Abstract
全国结核病科研协作组.我国初治痰结核菌阳性肺结核病人化疗实施情况调查[J].Chinese journal of Epidemiology,1995,16(4):220-222
我国初治痰结核菌阳性肺结核病人化疗实施情况调查
A Study on the Implementation of Primary Chemotherapy to Pulmonary Tuberculosis with Positive Bacillus
Received:December 03, 1994  Revised:February 27, 1995
DOI:
KeyWord: 结核  化疗
English Key Word: Tuberculosis  Chemotherapy
FundProject:
Author NameAffiliation
Tian Xi-zhong National Cooperative Organization on Tuberclusis Research, Ministry of Health Tuberculosis Contral Center, Beijing 101149 
Hits: 1180
Download times: 409
Abstract:
      对全国132个协作单位11729例初治痰结核菌阳性(初治菌阳)肺结核病人进行化疗实施的队列研究,发现一年的痰菌阴转率为80.0%,使用规范化疗方案仅占48.0%,卫生部推行的统一标准六个月短程化疗方案只有39.8%,60.0%的病人疗程过长,初始耐药病人二年复发率为7.6%;规范的化疗管理需要加强。
English Abstract:
      A cohort study on chemotherapy implementation program with regards to newly detected bacillus positive pulmonary tuberculosis patients in 132 medical units was carried out. Results showed that a) one year sputum negative conversion rate was 80%; b) only 48.1% of the patients had received the standardization six-month short-course chemotherapy regimens promoted by M. O. H; c) among 60% of the patients the duration of treatement had been too long; d) the two-year relapse rate of initial drug-resistant patients was 7.6%. The result suggested that the standardized chemotherapy program should be strenghened.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close